Skip to main content

Table 5 Overall survival of the patients grouped by LDH levels

From: Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

LDH level (U/mL)

Overall survival (months)

P

PPTR group

Non-PPTR group

≤245

22.43 (4.07–86.73)

15.63 (2.80–64.50)

<0.001

246–380

19.50 (4.70–65.37)

12.23 (2.33–44.43)

0.243

>380

16.83 (2.77–73.20)

15.37 (3.23–41.33)

0.892

  1. Each value is presented as median followed by range in parentheses
  2. The overall survival was compared between PPTR and non-PPTR group, and the differences were analyzed using the log-rank test
  3. LDH lactate dehydrogenase, PPTR palliative primary tumor resection